Understanding the Treatment Preferences of People Living with Schizophrenia in Australia; A Patient Value Mapping Study
Understanding the Treatment Preferences of People Living with Schizophrenia in Australia; A Patient Value Mapping Study is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Understanding the Treatment Preferences of People Living with Schizophrenia in Australia; A Patient Value Mapping Study have?
Understanding the Treatment Preferences of People Living with Schizophrenia in Australia; A Patient Value Mapping Study has 21 citations in the OpenAlex counts ScholarIQ stores.
When was Understanding the Treatment Preferences of People Living with Schizophrenia in Australia; A Patient Value Mapping Study published?
Understanding the Treatment Preferences of People Living with Schizophrenia in Australia; A Patient Value Mapping Study has 2022 year in the ScholarIQ index.
What is the open-access status of Understanding the Treatment Preferences of People Living with Schizophrenia in Australia; A Patient Value Mapping Study?
Understanding the Treatment Preferences of People Living with Schizophrenia in Australia; A Patient Value Mapping Study has gold oa status in the ScholarIQ index.
What is the DOI of Understanding the Treatment Preferences of People Living with Schizophrenia in Australia; A Patient Value Mapping Study?
The DOI for Understanding the Treatment Preferences of People Living with Schizophrenia in Australia; A Patient Value Mapping Study is on the source record.
What is the PMID of Understanding the Treatment Preferences of People Living with Schizophrenia in Australia; A Patient Value Mapping Study?
The PMID for Understanding the Treatment Preferences of People Living with Schizophrenia in Australia; A Patient Value Mapping Study is on the source record.
What is the OpenAlex record for Understanding the Treatment Preferences of People Living with Schizophrenia in Australia; A Patient Value Mapping Study?
The OpenAlex for Understanding the Treatment Preferences of People Living with Schizophrenia in Australia; A Patient Value Mapping Study is on the source record.